COVID-19 Has Crystallized the Need for Effective Diagnostics at the Point-of-Need
Proactive Diagnostics is developing a future-proof, customizable solution to test for a panel of respiratory viruses, with central lab precision at the Point-of-Need. Our solution will enable improved care of high-risk groups, reduction of antibiotic stewardship, and effective management and containment of respiratory viral outbreaks.
Events of the past year prove that current testing methods fail to provide real-time and reliable information to medical staff, politicians, and the public and enable calculated decision-making. Our breakthrough Q-SENS platform possesses all traits to serve as a robust and highly affordable tool for wide deployment and quick response to emerging viruses with epidemic and pandemic potential.
Cytokine Profiling to Predict Disease Severity
Research suggests that appropriate cytokine profiling can provide valuable insight in assessing the resilience of the patient immune system to infection by a pathogen and serve to predict disease progression.
In the case of COVID-19, a continuous high level of some cytokines referred to as a "Cytokine Storm" was shown to lead to Acute Respiratory Distress Syndrome (ARDS), resulting in a high mortality rate.
The Q-SENS can enable rapid multiplex cytokine and coagulation pathway assessment from a single blood drop, easily drawn by a finger prick by an untrained individual. This capability could aid medical staff in optimizing patient care and medical resource allocation.
We look forward to working towards this important mission and welcome opportunities to collaborate with experts in the fields of immunology and host response.
The Q-SENS Brings a New Level of Pandemic Preparedness
Frequent and accessible antigen testing for viral structural proteins could go a long way in allowing breaking transmission chains early and providing a real-time and transparent image of a disease's course of spread.
This solution will enable policymakers and healthcare systems to make informed decisions about lockdowns and other restrictive measures and combat fake news and misinformation.
We envision the Q-SENS becoming the platform of choice to enable rapid Point-of-Care antigen testing and mass population screening at any Point-of-Care and Need.